Alexandra Glucksmann, Ph.D.
DirectoratRegenxbio· In proxies 2023–2025
Alexandra Glucksmann, Ph.D. sits on 4 public boards.
Experience
- RegenxbioPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role -67%
- Scenic Biotech BVPublic company · 9 yr
- Director2017 – Present · 9 yrNo stock prices for these years
- Edity TherapeuticsPublic company
- Director? – PresentNo stock prices for these years
- Rouge TherapeuticsPublic company
- Director? – PresentNo stock prices for these years
- TME Pharma NVPublic company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?